Table 2.
Prospective first-line therapy trials in adult PTLD after SOT (adapted from Trappe et al17 )
ORR indicates overall response rate; OS, overall survival; CI, confidence interval; and PD, progressive disease.
*This trial included pediatric patients and second-line therapy.
†Follow-up of less than 2 years median OS is not yet reached; OS at 6 months was 79%.
